Because neoplastic elements in human tumors were immunoreactive to IL-6 antibodies and several cancer cell lines constitutively secreted IL-6 [39,40], we investigated whether cancer-associated genetic changes might upregulate IL-6 gene expression. The gene discussed is IL6; the disease is cancer.